- Quality and Safety: Medicines > Quality Assurance
- Quality and Safety: Medicines > Safety and Efficacy
(1995; 36 pages) [French] [Spanish]
4.16 Final report
After completion of the trial, a final report must be drawn up and submitted to the drug regulatory authority. The report should be dated and signed by the investigator in accordance with local regulations to verify responsibility for the validity of the data.